Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6658.0000 42.00 (0.63%)
NSE Jun 27, 2025 15:31 PM
Volume: 545.2K
 

6658.00
0.63%
BOB Capital Markets Ltd.
Q3 sales/EBITDA/PAT were 0.6%/7.5%/22.3% above our estimates. PAT was higher than estimated due to the adoption of the new tax regime
Divi's Laboratories .. has an average target of 5900.88 from 8 brokers.
More from Divi's Laboratories Ltd.
Recommended